For instance, in chronic lymphocytic leukaemia (CLL), BCL-2 mutations have recently been reported that render BCL-2 unable to effectively bind the BH3-mimetic venetoclax, causing apoptotic resistance34–37. The gene discussed is BCL2; the disease is B-cell chronic lymphocytic leukemia.